Lauxera Capital Partners Invests €10m In Matrix Requirements

Lauxera Capital Partners announces the acquisition of a majority stake in a German Medtech software company, Matrix Requirements, (a MedTech quality management software provider). The software editor helps medical device companies meet their growing need for quality and regulatory compliance in a world where the lines between medical devices and software are blurring.

Matrix Requirements is a perfect fit for medical device companies developing complex products, often with significant software-dependent features. In addition to more traditional MedTech clients, Matrix’s product portfolio is designed to serve the fast-growing “software as a medical device” field encompassing digital therapeutics, connected devices, and technologies leveraging machine learning/artificial intelligence.

This is the seventh investment made by Lauxera Growth I, a growth and growth buy-out fund dedicated to investing in European HealthTech.

More than 180 medtech companies rely on MatrixALM and MatrixQMS applications

Founded in 2014 by Wolfgang Huber (former VP R&D at Advanced Medical Diagnostics and co-founder of NeoMed Software) and Yves Berquin (former Program Manager at Advanced Medical Diagnostics and CTO at SleepOnWeb), Matrix Requirements has grown into a leader in the MedTech quality management system software space with two highly differentiated solutions:

• MatrixALM, flexible software for managing medical device technical files with the goal of accelerating regulatory approvals (CE marking, FDA approval, etc.) and reducing non-compliance risk
• MatrixQMS, a quality management system solution enabling MedTech companies to develop and maintain their own quality systems reflecting the specific needs of their products in compliance with ISO and FDA standards.

To date, these solutions have been adopted by more than 180 MedTechs throughout the world, including large accounts (Stryker, BBraun, Roche, Sanofi…), start-ups (Mindmaze, UgenTec, Robocath…) and academic institutions (University of Arkansas). To meet their needs, Matrix Requirements has a growing team of engineers and MedTech quality management system experts specialized in medical devices. Matrix Requirements is ISO13485 and ISO 27001 certified.

Wolfgang Huber and Yves Berquin, co-founders of Matrix Requirements, said: “We are delighted to partner with Lauxera to accelerate the development of Matrix Requirements and our products. We share the vision of continuing to offer the best solutions to make Matrix Requirements a global leader in its industry. This transaction provides the company with the means to significantly accelerate its growth by adding to the team of which we are very proud. Lauxera’s entrepreneurial culture, skills and experience make it an ideal partner. We are looking forward to this new step in our development.”

Samuel Levy, Founding Partner of Lauxera Capital Partners, added: “Yves and Wolfgang have built remarkable MedTech quality management system products that delight customers and accelerate time to market for life saving medical devices.

The MedTech eQMS software market exceeds $2.5 billion in size and is growing rapidly as software replaces paper and regulatory scrutiny grows. We are excited to work hand in hand with the Matrix management team to strengthen the company’s commercial engine and enable our customers to navigate rigorous audits without non-conformities.”

Laurent Grandidier, serial entrepreneur in the MedTech sector and Chairman of the Board of Directors concluded: “Unlike other software players, Matrix is entirely focused on MedTech companies. This focus is relevant in an increasingly complex regulatory environment.

More than ever, medical device manufacturers need risk management tools for the development of their technologies. The solutions developed by the Matrix team are the perfect answer to the challenges of digitization, cybersecurity, and traceability of these devices under development. Matrix products ensure that device designers are agile from the first stages of R&D through marketing registration on a global basis”.

Lauxera Capital Partners was advised by Tricon Law on legal matters in Germany (Hartmut Wollstadt & Thorsten Lill), Goodwin Luxembourg on legal and taxation matters in Luxembourg (Alexandrine Armstrong-Cerfontaine & Bastien Voisin), Flick Gocke Schaumburg on taxation matters in Germany (Matthias Full & Anne-Catherine Lorek), Ebner Stolz on taxation matters in Luxembourg (Claus Bähre), Luther on legal matters in Luxembourg (Hervé Leclercq & Amaury François), and Dechert (Sabina Comis & Etienne Bimbeau) on overall structuring and taxation matters in France.

Hot this week

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.